Abstract-Teleocidin
(5 /tg/mouse), a potent tumor promoting indole alkaloid from Streptomyces, induced epidermal ornithine decarboxylase (ODC) in CD-1 mice. Teleocidin-caused ODC induction was inhibited by the treatment of indo methacin (2 ,ttmol/mouse), a selective cyclooxygenase inhibitor, and p-bromo phenacyl bromide (BPB) (30 umol/mouse), a phospholipase A2 inhibitor. Teleocidin-caused ODC induction inhibited by indomethacin was completely restored by concurrent application of prostaglandin E2 (PGE2) (140 nmol/mouse). On the other hand, teleocidin-caused ODC induction inhibited by BPB was not restored by the treatment of mice with PGE2, but partially restored by the treatment with arachidonic acid (1 ,ttmol/mouse). Treatment of mice with lipoxygenase inhibitors such as BW755C (30 itmol/mouse), nordihydroguaiaretic acid (NDGA) (30 itmol/mouse), quercetin (10 /tmol/mouse), and 2,3,5-trimethyl-6-(12 hydroxy-5,10-dodecadiynyl)-1,4-benzoqu1none (AA861) (10 i mol/mouse) clearly suppressed ODC induction by teleocidin. Moreover, both NDGA (30 /t.mol/mouse) and quercetin (10 ftmol/mouse) inhibited the restoring effect of PGE2. Therefore, our present results suggest that arachidonate metabolites, i.e., not only cyclooxygenase product(s) but also lipoxygenase product(s), are involved in the mechanism of ODC induction by teleocidin. Materials and Methods Female CD-1 mice (Charles River, Atsugi, Japan), 7 to 8 weeks old, were used. The dorsal hair of each mouse was shaved with clippers at least 2 days before using, and only those mice showing no regrowth of hair were used. All chemicals were dissolved in reagent grade acetone and applied to the shaved area in a volume of 0.2 ml using a micropipet. The inhibitors were applied to the mouse skin concurrently with teleocidin.
Five hours after the treatment of teleocidin, the mice were sacrificed by cervical dislo cation, and the skins were excised. The epidermis was separated by a brief heat treatment and then homogenized in 10 vol. of 20 mM Tris-HCI buffer (pH 7.2) with a Polytron PT-10 homogenizer for 10 to 15 sec at 4'C. The homogenate was centrifuged at 30,000 x g for 30 min at 4'C. O DC activity of the 30,000xg supernatant was determined by measuring the release of 14C 02 from DL [1 -14C]ornithine as described previously (5, 7). In short, incubation was carried out for 60 min at 37° in the following medium: 0.4 /Imol pyridoxal phosphate, 1.0 iimol dithiothreitol, 0.2 ,umol L-ornithine, 30 ,umol Tris-base (pH 7.2), 0.5 ml epidermal extract, and 0.5 ,uCi DL-[1 -14C]ornithine (57.3 mCi/ mmol) in a final volume of 2.0 ml. The generated CO2 and 14C 02 were absorbed into hyamine 10X placed in a central well of the incubation flask. The reaction was stopped by 2 M citric acid, and incubation was continued for an additional 30 min to ensure complete absorption of 14C 02. The hyamine solution was transferred into a scintillation vial containing 10 ml of toluene based scintillater, and radioactivity was measured.
Enzyme activity was expressed as nmol CO2 in 60 min per mg protein. The protein concentration of the epidermal extract was measured by the method of Lowry et al. (13), with bovine serum albumin as the standard. None of the drugs which we used directly interfered with the ODC assay system.
Teleocidin was isolated from Streptomyces as reported previously (2). It is a mixture of 
Results
A single topical application of teleocidin (5 ,ug/mouse) resulted in a rapid transient increase in mouse epidermal ODC activity, as reported previously (4). A peak of activity was observed at 5 hr after treatment. The teleocidin-caused ODC induction was inhibited by BPB (5 ssmol/mouse) ( Fig. 1 ) and indomethacin (2 ,cmol/mouse) ( Table  1) . Inhibition of the teleocidin-caused ODC induction was dose-dependent as in the case of TPA-caused ODC induction (6, 7). The inhibition of teleocidin-caused ODC induction by indomethacin was fully coun teracted by application of PGE2 (140 nmol/ mouse) to the mice (Table 1) . However, the inhibition ofteleocidin-caused ODC induction by BPB could not be counteracted by PGE2 (Fig. 1) . On the contrary, arachidonic acid (1 ,umol/mouse) partially restored the teleocidin-caused ODC induction inhibited by BPB (Fig. 2) . As reported previously (6, 7), application of PGE2 or arachidonic acid alone does not induce epidermal ODC activity. Moreover, PGE2 applied with TPA shows no potentiating action on ODC induction by TPA (6). Table 2 shows the effects of several lipoxygenase inhibitors on the induction of ODC by teleocidin. BW755C (30 amol/ mouse), NDGA (30 acmol/mouse), quercetin (10 ,emol/mouse) and AA861 (10 /imol/ mouse) clearly suppressed the teleocidin caused ODC induction. In addition, treatment The present results showed that treatment of mice with indomethacin, a selective cyclooxygenase inhibitor, inhibited the induction of epidermal ODC by teleocidin and that the application of PGE2, a major cyclooxygenase product in mouse epidermis of this strain (6, 14), counteracted the inhibitory effect of indomethacin.
Similar to the TPA-caused ODC induction (6, 7), PGE2 may also play a crucial role in ODC induction by teleocidin. On the other hand, PGE2 failed to overcome the inhibitory effect of BPB, a phospholipase A2 inhibitor (22) . In addition, the inhibitory effect of BPB was partially but significantly overcome by arachidonic acid. These results indicate that not only cyclooxygenase product(s) but also lipoxygenase product(s) of arachidonic acid are involved in the mechanism of ODC induction by teleocidin, similar to TPA caused ODC induction (7, 8, 10, 11).
The main lipoxygenase product of arachidonic acid is identified as 12-hydroxy 5, 8, 10, 1 4-eicosatetraenoic acid (12 HETE) in mouse epidermis (10, 23), as in human (23) and guinea pig epidermis (24) . The main cyclooxygenase product of arachidonic acid is PGE2 in mouse epidermis as reported previously (14). NDGA (25), quercetin (10, 26) and AA861 (27) potently inhibit epidermal lipoxygenase activity (10, 14), but do not inhibit cyclooxygenase activity (14, 28). BW755C usually inhibits both lipoxygenase and cyclooxygenase (29), although we did not check it in mouse epidermis.
Indomethacin does not inhibit epidermal lipoxygenase activity, but potently inhibits epidermal cyclooxygenase activity (28) . The present results clearly show that teleocidin -caused ODC induction was inhibited by treatment of mice with BW755C, NDGA, quercetin and AA861. In addition, NDGA and quercetin counteracted the restoring effect of PGE2 on the teleocidin caused ODC induction inhibited by indo methacin. These results further support our finding that lipoxygenase product(s) are involved in the mechanism of teleocidin caused ODC induction.
Teleocidin inhibits the specific binding of phorbol ester to membrane receptors with a potency similar to that of TPA (15, 30) . Thus, teleocidin and TPA appear to bind the same receptor, which is considered to be calcium activated, phospho!ipid-dependent protein kinase (31) , and produce similar biological effects. In agreement with this, the present results indicate that TPA and teleocidin induce ODC by acting through a similar mechanism which involves the lipoxygenase pathway of arachidonic acid (7-12). Inter estingly, a similar contribution of lipoxyge nase product(s) in the mechanism of teleocidin-induced insulin secretion from isolated rat pancreatic islets, which is also common to TPA and glucose-induced insulin secretion (32, 33) , has been suggested (18 
